Novel aminobenzamide derivative
This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R is -S(O)p-A, -S-(O)q-B or -O-D, wherein p and q, which are the same or different, each represent an integer from 0 to 2, A is a straight chain C1-C10 alkyl group which...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
02.04.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R is -S(O)p-A, -S-(O)q-B or -O-D, wherein p and q, which are the same or different, each represent an integer from 0 to 2, A is a straight chain C1-C10 alkyl group which may be substituted by R , and B and D each independently represent R which may be substituted by R ; R is a hydrogen atom, a halogen atom, or a straight chain or branched C1-C6 alkyl group which may be substituted by R ; X and X each independently represent N or CH, but cannot both be N; the formula (II): shows a monocyclic or bicyclic heteroaryl group which has a nitrogen atom adjacent to the carbon atom bonded to the amide group, and the heteroaryl group may be substituted by R ; R is R , or a hydrocarbon group which may be substituted by R ; R is, for example, a hydrogen atom or amino; and R is, for example, phenyl, thiazolyl, pyridyl or methylene dioxyphenyl. The compound according to this invention has a glucokinase activation effect, and for example, is useful in the treatment and prevention of diabetes mellitus, and in the prevention of its complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy and diabetic arteriosclerosis. |
---|---|
AbstractList | This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R is -S(O)p-A, -S-(O)q-B or -O-D, wherein p and q, which are the same or different, each represent an integer from 0 to 2, A is a straight chain C1-C10 alkyl group which may be substituted by R , and B and D each independently represent R which may be substituted by R ; R is a hydrogen atom, a halogen atom, or a straight chain or branched C1-C6 alkyl group which may be substituted by R ; X and X each independently represent N or CH, but cannot both be N; the formula (II): shows a monocyclic or bicyclic heteroaryl group which has a nitrogen atom adjacent to the carbon atom bonded to the amide group, and the heteroaryl group may be substituted by R ; R is R , or a hydrocarbon group which may be substituted by R ; R is, for example, a hydrogen atom or amino; and R is, for example, phenyl, thiazolyl, pyridyl or methylene dioxyphenyl. The compound according to this invention has a glucokinase activation effect, and for example, is useful in the treatment and prevention of diabetes mellitus, and in the prevention of its complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy and diabetic arteriosclerosis. |
Author | JUNICHI EIKI TOMOHARU IINO YASUFUMI NAGATA TERUYUKI NISHIMURA |
Author_xml | – fullname: JUNICHI EIKI – fullname: YASUFUMI NAGATA – fullname: TERUYUKI NISHIMURA – fullname: TOMOHARU IINO |
BookMark | eNrjYmDJy89L5WSQ98svS81RSMzNzMtPSs2rAjJSUhVSUosyyxJLMstSeRhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJvGOokYGBsZGRoaGJgZOTkTGRygAJ0Cg2 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2003221140BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2003221140BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:55:46 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2003221140BB23 |
Notes | Application Number: AU20030221140 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090402&DB=EPODOC&CC=AU&NR=2003221140B2 |
ParticipantIDs | epo_espacenet_AU2003221140BB2 |
PublicationCentury | 2000 |
PublicationDate | 20090402 |
PublicationDateYYYYMMDD | 2009-04-02 |
PublicationDate_xml | – month: 04 year: 2009 text: 20090402 day: 02 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | BANYU PHARMACEUTICAL CO., LTD |
RelatedCompanies_xml | – name: BANYU PHARMACEUTICAL CO., LTD |
Score | 2.7373688 |
Snippet | This invention relates to a novel compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, wherein R is -S(O)p-A, -S-(O)q-B or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Novel aminobenzamide derivative |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090402&DB=EPODOC&locale=&CC=AU&NR=2003221140B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFPVNp-LXtA-jb8Uar-36MMR-MYR1QzbZ22iaFAazHa5u4F_vNay6J307Erh8cL9cfrnkAtDJ7ERkGZNGimnXQDJhwhxHg1uIAoUQD-rnuUFs9yf4MrWmDVjUb2FUntCNSo5IiEoJ76Var5e_h1iBulu5uudzKiqeonEv0Gt27JJNMj3weuFoGAx93feJSerxq7qDxYjsoOnRgr1XbaSrTPvhm1e9S1nuOpXoGPZHpC8vT6Ah8xYc-vXfay04GGxD3iRu0bc6hbu4WMuFlrzP84LL_IsEITVBNrRW6bvPoBOFY79vUEuzn4HNnic73fLY4zk0ifPLC9C4a8rMlQLRQfIYTiJT27UIjMJyhGuxS2j_qerqn_prOKrDIia7gWb58Snb5F1Lfqsm5Ru-ynxG |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED_GFOebTsWvuT6MvhVrTFv7MMS2K1XXbkgneytLk8JgtsPVCf71XsOqe9K3I4HLB_fL5ZdLLgC9zJzxLCNCS2l6p1E0YcQcoxozKOWUc34jf54LIzOY0KepMW3Aon4LI_OEfsrkiIioFPFeyvV6-XuI5cm7latrNsei4t6P-55as2MbbZKontMfjEfeyFVdF5mkGr3IO1gEyQ7VHVywd6wqP2-1eXp1qncpy22n4h_A7hj15eUhNETehpZb_73Whr1wE_JGcYO-1RF0o2ItFsrsbZ4XTORfKHChcLShtUzffQw9fxC7gYYtJT8DSx4mW91yyO0JNJHzi1NQmK2LzBacUouix7BmIjVtA8HIDYvbBjmDzp-qzv-p70IriMNhMnyMni9gvw6R6OQSmuX7h-igpy3ZlZygb7a0fzM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+aminobenzamide+derivative&rft.inventor=JUNICHI+EIKI&rft.inventor=YASUFUMI+NAGATA&rft.inventor=TERUYUKI+NISHIMURA&rft.inventor=TOMOHARU+IINO&rft.date=2009-04-02&rft.externalDBID=B2&rft.externalDocID=AU2003221140BB2 |